Skip to main content
Clinical Trials/IRCT20210918052511N2
IRCT20210918052511N2
Recruiting
Phase 2

Assessment of the efficacy of hydrogel-based wound dressing containing allantoin and silver nanoparticles in the treatment of second-degree burn wounds: A randomized clinical trial

Mashhad University of Medical Sciences0 sites86 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Burn patients.
Sponsor
Mashhad University of Medical Sciences
Enrollment
86
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients between the ages of 2 and 60 are eligible to participate.
  • Patients with second\-degree burns diagnosed by the relevant physician
  • Patients with burns that are less than or equal to 20%
  • Patient with second\-degree burns in upper and lower limbs and anterior trunk
  • The wound is examined by a plastic and burn surgeon for necrosis and the depth of the burn. If the burned area is not a candidate for early surgery and can be healed without surgery and with minimal complications, the patient will be eligible to the study.

Exclusion Criteria

  • Delayed visit and the presence of obvious wound infection at the first visit by an infectious disease specialist
  • Patients who are receiving chemotherapy
  • Patients taking corticosteroids or cytotoxic medicines
  • Cancer, cytotoxic drugs, immunosuppressants, and the presence of chronic diseases other than diabetes that affect wound healing, such as severe vascular disease, lupus, rheumatoid arthritis, and renal failure
  • The presence of an underlying disease leads to a defective immune system
  • Diabetic patients
  • Taking drugs that lead to a defective immune system.
  • Burns in the back of the trunk, face, head and perineum

Outcomes

Primary Outcomes

Not specified

Similar Trials